X. Ouyang

发表

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Jianying Zhou, Erdem Goker, Jun Zhao, 2019, The Lancet.

Twist, an independent prognostic marker for predicting distant metastasis and survival rates of esophageal squamous cell carcinoma patients

Kun Li, X. Ouyang, F. Xie, 2009, Clinical & Experimental Metastasis.

Clinical study on treatment of primary hepatocellular carcinoma by Shenqi mixture combined with microwave coagulation.

X. Ouyang, Jian-jun Lin, C. Jin, 2005, Chinese journal of integrative medicine.

Bone Markers for Monitoring Efficacy in Patients with Bone Metastases Receiving Zoledronic Acid: A Review of Published Data

X. Ouyang, Qian Huang, 2013, The International journal of biological markers.

Biochemical-markers for the diagnosis of bone metastasis: a clinical review.

X. Ouyang, Qian Huang, 2012, Cancer epidemiology.

Ramdomized 3-armed phase III study of S-1 monotherapy versus S-1/CDDP (SP) versus 5-FU/CDDP (FP) in patients (pts) with advanced gastric cancer (AGC): SC-101 study

L. Shen, Yuankai Shi, S. Qin, 2008 .

[Efficacy and toxicity of pemetrexed or gemcitabine combined with cisplatin in the treatment of patients with advanced non-small cell lung cancer].

Cheng Huang, Shucai Zhang, S. Jiao, 2012, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Association of TIP30 expression and prognosis of hepatocellular carcinoma in patients with HBV infection

S. Zhang, Lizhi Lv, X. Ouyang, 2016, Cancer medicine.

Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction.

Ying Cheng, Y. Ba, Jianming Xu, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma

Qun Chen, Shanshan Huang, X. Ouyang, 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

CacyBP/SIP enhances multidrug resistance of pancreatic cancer cells by regulation of P-gp and Bcl-2

X. Chen, J. Li, X. Ouyang, 2013, Apoptosis.

Expression and prognostic significance of cyclin-dependent kinase inhibitor 1A in patients with resected gastric adenocarcinoma.

Wei Liu, Qiaojia Huang, X. Ouyang, 2017, Oncology letters.

Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis

Shanshan Huang, X. Ouyang, Xiong Chen, 2016, Disease markers.

Analysis of preoperative concurrent chemoradiotherapy for superior sulcus lung tumor

X. Ouyang, Wen-wu Wang, Hao Jiang, 2007 .

Additive effects of EGF and IL-1β regulate tumor cell migration and invasion in gastric adenocarcinoma via activation of ERK1/2.

Wei Liu, Qiaojia Huang, X. Ouyang, 2014, International journal of oncology.

BAX and CDKN1A polymorphisms correlated with clinical outcomes of gastric cancer patients treated with postoperative chemotherapy

Wei Liu, Qiaojia Huang, X. Ouyang, 2014, Medical Oncology.

Predictive biochemical-markers for the development of brain metastases from lung cancer: clinical evidence and future directions.

X. Ouyang, Qian Huang, 2013, Cancer epidemiology.

A GG allele of 3′-side AKT1 SNP is associated with decreased AKT1 activation and better prognosis of gastric cancer

Qiaojia Huang, X. Ouyang, Jian-ming Tan, 2014, Journal of Cancer Research and Clinical Oncology.

Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma.

Lin Lin, J. Li, Qun Chen, 2017, Pathology, research and practice.

IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9

Wei Liu, Qiaojia Huang, X. Ouyang, 2014, Molecular Cancer.

IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9

Jianming Tan, Lihong Dong, Qiaojia Huang, 2014, Molecular Cancer.

Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer

C. Bai, B. Han, Qiang Li, 2018, Investigational New Drugs.

Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study

Wei Li, R. Feng, Yongping Song, 2016, BMC Cancer.

Three-year Follow-up on the Safety and Effectiveness of Rituximab Plus Chemotherapy as First-Line Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in Real-World Clinical Settings in China: A Prospective, Multicenter, Noninterventional Study

Changping Wu, Wei Li, R. Feng, 2018, Chinese medical journal.

Programmed Death-Ligand 1 Expression Predicts Tyrosine Kinase Inhibitor Response and Better Prognosis in a Cohort of Patients With Epidermal Growth Factor Receptor Mutation-Positive Lung Adenocarcinoma.

Yun Dai, X. Ouyang, Xiong Chen, 2015, Clinical lung cancer.

Regulation and expression of aberrant methylation on irinotecan metabolic genes CES2, UGT1A1 and GUSB in the in-vitro cultured colorectal cancer cells.

J. Li, Xi Chen, X. Ouyang, 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Effect of Feitai Capsule (肺泰胶囊) on quality of life and progression-free survival of patients with unresectable non-small cell lung cancer

Zhizhen Liu, Jian Du, Jie Li, 2012, Chinese Journal of Integrative Medicine.

Predictive SNPs for radiation-induced damage in lung cancer patients with radiotherapy: a potential strategy to individualize treatment

X. Ouyang, F. Xie, Qian Huang, 2015, The International journal of biological markers.

Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma

Shanshan Huang, X. Ouyang, Xiong Chen, 2016, Tumor Biology.

Value of Oncogenes for the Prediction of Brain Metastases at Initial Diagnosis: A Review of Published Data

X. Ouyang, Qian Huang, 2014, The International journal of biological markers.

The role of miRNAs in bone metastasis and their significance in the detection of bone metastasis: a review of the published data.

X. Ouyang, Qian Huang, 2015, Future oncology.

Expression of pim-1 in Tumors, Tumor Stroma and Tumor-Adjacent Mucosa Co-Determines the Prognosis of Colon Cancer Patients

Houjie Liang, X. Ouyang, Jian-jun Li, 2013, PloS one.

Influence of UGT1A1 gene methylation level in colorectal cancer cells on the sensitivity of the chemotherapy drug CPT-11.

J. Li, Xi Chen, X. Ouyang, 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial

Ying Cheng, Jianming Xu, Yunpeng Liu, 2019, Cancer communications.

Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial

Ying Cheng, Jianming Xu, Wei Li, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical randomized comparative trial of DICE regimen and CHOP regimen in treating intermediate and high grade non-Hodgkin’s lymphoma

X. Ouyang, F. Xie, Zongyang Yu, 2008 .

Gefitinib induces lung cancer cell autophagy and apoptosis via blockade of the PI3K/AKT/mTOR pathway

J. Li, X. Ouyang, Zhong-quan Zhao, 2016, Oncology letters.

Clinical significance of Her-2 protein expression in gastric cancer

X. Ouyang, F. Xie, Juan-juan Chen, 2010 .

Clinical application of OxyContin hydrochloride controlled release tablets in treatment of pain suffered from advanced cancer

X. Ouyang, Zongyang Yu, Wen-wu Wang, 2012 .

Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study

Changping Wu, Wei Li, R. Feng, 2016, BMC Cancer.

A pilot study of safety and efficacy of pandimex with or without paclitaxel in the treatment of advanced solid tumors

W. Fang, W. Jia, X. Ouyang, 2005 .

A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.

Baorui Liu, Changping Wu, Y. Shu, 2016, Experimental and therapeutic medicine.

BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis

Shanshan Huang, X. Ouyang, Xi Chen, 2018, The International journal of biological markers.

Prognostic value of differential CCND1 expression in patients with resected gastric adenocarcinoma

Wei Liu, Qiaojia Huang, X. Ouyang, 2014, Medical Oncology.

[Study on the relationship between vascular endothelial growth factor and syndrome type of traditional Chinese medicine in patients with gastric carcinoma].

X. Ouyang, Wen Chen, Q. Lin, 2007, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.